Does SOTATERCEPT-CSRK Cause Therapy cessation? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Therapy cessation have been filed in association with SOTATERCEPT-CSRK (WINREVAIR). This represents 1.0% of all adverse event reports for SOTATERCEPT-CSRK.
16
Reports of Therapy cessation with SOTATERCEPT-CSRK
1.0%
of all SOTATERCEPT-CSRK reports
0
Deaths
14
Hospitalizations
How Dangerous Is Therapy cessation From SOTATERCEPT-CSRK?
Of the 16 reports, 14 (87.5%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTATERCEPT-CSRK. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SOTATERCEPT-CSRK Cause?
Headache (187)
Epistaxis (151)
Diarrhoea (132)
Haemoglobin increased (100)
Dyspnoea (93)
Fatigue (93)
No adverse event (93)
Dizziness (90)
Nausea (88)
Dyspnoea exertional (61)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which SOTATERCEPT-CSRK Alternatives Have Lower Therapy cessation Risk?
SOTATERCEPT-CSRK vs SOTORASIB
SOTATERCEPT-CSRK vs SOTROVIMAB
SOTATERCEPT-CSRK vs SOVALDI
SOTATERCEPT-CSRK vs SOYBEAN OIL
SOTATERCEPT-CSRK vs SPARSENTAN